ArticleNeuropsychiatric disease and treatment2019

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Celestino Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.